An interventional study of Iyengar Yoga and Health Education Control in Prolonged Grief Disorder, sponsored by Medical College of Wisconsin. Not yet recruiting at 1 site in United States. Open to participants aged 40 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Medical College of Wisconsin · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Prolonged Grief Disorder with a site in United States — 4 open to participants now, 5 under way, none of them phase 3. Prolonged Grief Disorder · United States.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, this one is the 4th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2027, is one of 10 with no phase, and was the 15th registered.
40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.
Browse Prolonged Grief Disorder studies →4 of the 15 studies in Prolonged Grief Disorder with a site in United States are open now. Recruiting first, the newest first:
University of Virginia · Sites in United States
Ages 18–65 · Healthy volunteers
RAND · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 8+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 9 Prolonged Grief Disorder studies recruiting now, 7 set no upper age limit and 2 stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 40 Years to 89 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 126 is above the median of 73 across 36 interventional studies indexed under Prolonged Grief Disorder.
Median enrollment 42 across the 14 interventional studies, 0 across the 1 observational. Of the 7 that completed or were terminated, 3 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 15 has an industry lead sponsor. The 10 most frequent:
Medical College of Wisconsin is the lead sponsor of 550 studies on the registry; 123 are open to participants now.
Of its 76 completed or terminated interventional studies of FDA-regulated products, 58 (76%) have results posted.
Medical College of Wisconsin has 2 studies filed under Prolonged Grief Disorder — fewer than ten, so there is no comparison to draw.
3 of the studies in Prolonged Grief Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05026827Medical College of WisconsinIyengar Yoga for Prolonged Grief Disorder | 2026-12 |
| NCT07318090University of PittsburghF-PGT - Prolonged Grief Treatment for Families Affected by Suicide | 2026-12-31 |
| NCT06724289University of VirginiaPsilocybin for Prolonged Grief Disorder | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Prolonged Grief Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
After losing a loved one, most successfully navigate acute grief and adapt to the loss within about 1 year, but in about 10%, prolonged grief disorder (PGD) ensues. This study is anticipated to provide novel evidence regarding the neurobiological mechanisms of PGD in older adults. The biological alterations identified here could provide targets to elucidate how currently available therapies work and inform novel mechanism-based interventions for treating late-life PGD.
The objectives of this study are to (1) identify functional brain network features that differentiate PGD from integrated grief, and (2) conduct a mechanistic study in older adults with PGD to test whether exposure to 10-weeks of IY and HE modulate brain network targets and clarify how network changes relate to clinical response.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will engage in 10 weekly IY classes
Behavioral: Iyengar Yoga
Participants will engage in 10 weekly socialization control group sessions
Behavioral: Health Education Control
Waitlist Control
Other: Waitlist Control to Crossover
Participants will engage in 10 weekly IY classes
Participants will engage in 10 weekly socialization control group sessions
Upon Step 1 study completion (week 10), participants in this group who continue to meet PGD criteria on the SCIP will enter Step 2 phase
Score on the Prolonged Grief 13-Revised (PG-13-R) scale
The investigators will measure change in the PG-13-R score from baseline to end of study. The PG-13-R scores range from 10 - 50 (higher scores indicate more severe grief symptoms).
Time frame: Baseline through study completion, up to 10 weeks
Plan to share: No — IPD cannot be shared due to confidentiality concerns for our patient population.
No publications or documents are linked to this record.
Start is estimated for Jan 2027; primary completion for Jan 2031, 48 months later.
Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 48 months is above that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical College of Wisconsin →